Lupron (leuprolide acetate) suppresses your body’s natural hormone signals so your fertility clinic can fully control the timing and preparation of your uterine lining before a frozen embryo is transferred. It does this by temporarily shutting down the pituitary gland, which prevents you from ovulating on your own and allows estrogen and progesterone to be given on a precise schedule. Not every FET cycle uses Lupron, but when it’s prescribed, it serves a specific purpose based on your medical history and protocol.
How Lupron Works in the Body
Lupron is a synthetic version of a hormone your brain already makes called GnRH (gonadotropin-releasing hormone). Under normal circumstances, GnRH tells your pituitary gland to release two key reproductive hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These hormones drive ovulation and regulate your menstrual cycle.
When Lupron is given continuously, something counterintuitive happens. At first, it causes a brief spike in LH and FSH, sometimes called a “flare.” But within about a week of daily use, the pituitary gland essentially shuts down production of both hormones. Researchers describe this as creating a temporary state similar to having no functioning pituitary activity along the reproductive axis. Without LH surging, ovulation cannot occur.
This shutdown is the whole point. In a programmed (also called “artificial” or “medicated”) FET cycle, your doctor wants to build your uterine lining with prescribed estrogen and then trigger the window for implantation with progesterone on an exact day. If your body were to ovulate spontaneously or produce its own hormones unpredictably, it could throw off that timing and force the cycle to be cancelled. Lupron eliminates that variable.
Why Some FET Cycles Use It and Others Don’t
There are several ways to prepare for a frozen embryo transfer. In a natural cycle FET, your doctor simply tracks your own ovulation and times the transfer around it, with no Lupron needed. In a medicated cycle without Lupron, estrogen and progesterone are given to build the lining, but the risk of a breakthrough ovulation still exists. Adding Lupron to a medicated cycle is the most controlled approach, giving the clinic full scheduling power.
A 2024 meta-analysis looking at different FET protocols concluded that the decision to use Lupron-based suppression should be based on each patient’s unique characteristics rather than applied routinely. For women with normal, regular ovulatory cycles, the added cost and time of Lupron pretreatment has not consistently shown enough benefit to justify routine use. However, certain groups appear to benefit more clearly.
Women with PCOS, for example, tend to have better outcomes with Lupron pretreatment before a medicated FET. Women with endometriosis or adenomyosis are another group frequently prescribed Lupron, sometimes as a longer course of depot injections for two or more months before transfer. The rationale there goes beyond just preventing ovulation.
The Endometriosis Connection
For patients with known or suspected endometriosis, Lupron does double duty. Beyond suppressing ovulation, it quiets the inflammatory endometriosis lesions that can interfere with implantation. Research published in the Journal of Assisted Reproduction and Genetics found that women with suspected endometriosis who were pretreated with two months of depot Lupron before FET had improved outcomes compared to untreated controls.
There’s also evidence that Lupron suppression can reset the uterine lining at a molecular level. Studies show it may restore the production of key implantation-related factors in the endometrium, including proteins that regulate how the lining develops and accepts an embryo. For women who have experienced repeated implantation failure, this “reset” effect is one reason clinics turn to a Lupron-suppressed cycle as a next step.
What the Cycle Looks Like Day to Day
If you’re on a Lupron-suppressed FET protocol, the cycle typically starts with daily subcutaneous injections in the weeks before your transfer. A common starting dose is 10 units injected each evening, later reduced to 5 units once suppression is confirmed. These are small injections, usually given in the belly or thigh with a thin insulin-type needle.
After you’ve been on Lupron for roughly one to two weeks, your clinic will bring you in for a “suppression check,” which involves blood work and an ultrasound. They’re looking for a thin, quiet uterine lining and low estrogen levels, confirming that your pituitary is effectively shut down and your ovaries are dormant. Once confirmed, you’ll begin taking estrogen (usually as pills or patches) to build the lining while continuing Lupron at the lower dose. After several days of estrogen, another ultrasound checks that the lining has thickened adequately. Then progesterone is started, and the embryo transfer is scheduled a set number of days later based on the embryo’s stage of development.
In the depot version, used more often for endometriosis patients, a single long-acting injection suppresses the system for about a month. This is typically given for one to three months before the lining-building phase begins, making the overall timeline significantly longer.
Side Effects During Suppression
Because Lupron temporarily shuts down your reproductive hormones, the side effects resemble a short-term menopause. Hot flashes are the most commonly reported symptom, often accompanied by night sweats. Headaches, fatigue, and mood changes (including irritability, tearfulness, or worsened depression) are also frequent. Joint or muscle pain, trouble sleeping, and decreased sex drive round out the most typical complaints.
Some women also notice injection-site reactions like redness or hardening, mild nausea, or dizziness. The good news is that these side effects are reversible. They fade once Lupron is stopped and your normal hormone production resumes, which typically happens within a few weeks of the last injection for the daily version, or a few weeks after the depot shot wears off.
The severity varies widely. Some women barely notice the suppression phase, while others find it genuinely difficult. If you’ve been prescribed a two-month depot course for endometriosis, the side effects last longer and can feel more pronounced than a shorter daily protocol.
Does Lupron Improve FET Success Rates?
This is the question most patients really want answered, and the data is nuanced. For the general population of women doing medicated FET, adding Lupron suppression does not guarantee higher pregnancy rates. One study comparing natural cycle FET to artificial (medicated) FET found live birth rates of 43% per transfer in the natural cycle group versus 30% in the medicated group. The miscarriage rate among women who did get pregnant was also lower in the natural cycle group (9% versus 20%). However, after adjusting for other variables like age and diagnosis, the type of FET protocol was not an independent predictor of live birth, suggesting that patient characteristics matter more than the protocol itself.
Where Lupron-suppressed protocols do appear to shine is in specific populations. Women with PCOS, endometriosis, adenomyosis, or a history of repeated implantation failure seem to benefit most. For these groups, the longer suppression protocols, particularly depot formulations, tend to show better pregnancy outcomes. A systematic review noted that long-term suppression with depot Lupron supposedly provides better results in these patient settings compared to shorter or no suppression.
For women with regular cycles and no complicating diagnoses, the added weeks of injections and the extra cost of Lupron may not translate into meaningfully better odds. This is why many clinics reserve it for cases where there’s a clear clinical reason rather than using it as a default for every FET.